Intradiscal injection of oxygen-ozone and intraforaminal steroid for the treatment of prolapsed intervertebral disc: 4 years follow up
DOI:
https://doi.org/10.18203/2320-6012.ijrms20151454Keywords:
Oxygen-ozone therapy, Prolapsed intervertebral disc, Low back pain, Ozone nucleolysisAbstract
Background: Intradiscal injection of Oxygen-Ozone (O2-O3) and intraforaminal steroid is a minimaliy invasive procedure for treatment of low back pain due to prolapsed intervertebral disc. About 9 out of 10 adults experience at least one episode of low back pain at some point in their lifetime. It has been studied that intradiscal and intraforaminal injection of mixture of O2-O3 and steroid produces good outcome than steroid only in such patients. The aim of the study was to evaluate long term therapeutic outcome of Intradiscal injection of Oxygen-Ozone (O2-O3) and intraforaminal steroid in Indian population.
Methods: There were 98 patients who were treated with intradiscal injection of O2-O3 and intraforaminal steroid 4 years’ back. All of them had clinical signs of lumbar nerve root compression along with CT and/or MR evidence of contained disk herniation. Eighty two patients were available for follow- up at 4 years. Retrospective study was carried out in those patients. All patients received about 3.5 to 4.0 ml of intradiscal O2- O3 mixture at concentration of 20-24- microgram/ml and intraforaminal injection of 40 mg of inj. Trimnicelone along with 2ml of local anesthetic. Clinical outcome after the injection was assessed by Modified MacNab method and the success of treatment was assessed by means of a visual analog pain scale and the Oswestry Disability Index.
Results: A significant reduction in the VAS was observed after 6 weeks and 6 months (from 8.6 to 5.4 and 6.0; p<0.001) in all patients; an excellent therapy response (VAS below 3.0) was achieved at 4 years. A significant improvement in ODI was registered in all patients (36 to 14.8; p < 0.001). Patients below 50 years had significantly better values in the VAS and the ODI score 4 years after treatment. Final VAS and ODI scores for patients with a single diseased segment were 4.2 and 28.0. The total effective rate according to Modified MacNab method (excellent and good /fair) was 93.9% at end of 6 months, 97.55% at 1 year and 4 years it was 97.55%. No patient was operated for spine surgery.
Conclusions: Intradiscal injection of O2-O3 and intraforaminal steroid is highly effective in relieving lower back pain in patients with lumbar disc herniation not responding to conservative therapy. There was significant clinical outcome even after 4 years.
Metrics
References
Kaki AM, Youseif E. Identifying neuropathic pain among patients with chronic low-back pain: use of the leeds assessment of neuropathic symptoms and signs pain scale. Reg Anesth Pain M. 2005;30:422.
Osborn AG. Nonneoplastic disorder of spine and spinal cord in diagnostic neuroradiology, St. Louis, Mosby. 1994;820-75.
Alexander A, Coro L. Intrdiscal inj. Of O2-O3 mixture for treatment of cervical disc herniation-Acta Neurochir Suppl. 2005;92:79-82.
Buric J,Molino L R- Ozone chemonucleolysis in non contained lumbar disc herniation- Acta Neurochir Suppl. 2005;92:92-7.
Iliakis E. Ozone treatment in low bak pain. Orthopaedics. 1995;1:29-33.
Muto M, Andreula C. Treatment of herniated lumbar disc by intradiscal and intraforaminal ozone inj. J NeuroRadiology. 2004;31(3):183-9.
Muto M. Low back pain and sciatica treatment with intradiscal transforaminal O2-O3 injection are experience-Radio med. 2008;113(5):695-706.
Andreula C. Lumbar Herniated disk and degenerative changes. Interventional spinal treatment with chemiodiscolysis with nucleoptesis with O3 and perigangliar infiltration in 150 cases. Rivista di Neuroradiologia. 2002;14:81-8.
Gallucci M, limbucci N.Sciatica treatment with intradiscal and intraforaminal inj. Of steroid and O2-O3 vs. steroid only-Radio 2007;242(3):907-13.
Steppan J. A meta-analysis of effectiveness and safety of ozone treatment for herniated lumbar disc, Journal of Vascular and interven. Radio. 2010;21(4):534-8.
Rilling S, Veibahn R. Use of ozone in medicine, New York, 1987.
Staal JB, de Bie R. Injection treatment for chronic Low back pain-Cochrane data base syst. 2008;16(3).
Bocei V. Biological & clinical Effects of O3- Br J. Biomed.Sc. 1990;56:270-9.
Paoloni M, Di Sante L. IM O2-O3 treatment in treatment of acute back pain lumbar: multicenter, randomized, double blind, clinical trial, active and simulated lumbar paravertebral injection. Spine. 2009;34(13):1337-44.
Das G, Ray S- Ozone chemonucleolysis for management of pain and disability in PIVD, Interval New Radio. 2009;15:330-4.
Oder B, Loewe M. CT guided O3/steroid for treatment of the degeneration specially diseases effect of age, gender, disc pathology. & multi-segments -Neuro Radio. 2008-50(9);777-85.
Muto M, Andreula C , Treatment of herniated lumbar disc by intradiscal and intraforaminal ozone inj. J. NeuroRadiology. 2004;31(3):183-9.
Five and Ten Year Follow-up on Intradiscal Ozone Injection for Disc Herniation Josip Buric, MD, Luca Rigobello, MD, David Hooper PhD,International journal of spine surgery vol 8 article 17.
Bo W, Longyi C. Pyogenic discitis at C3-C4 with epidural abscess involving c1-c4 alter intradiscal O2-O3 chemonucleolysis- a case report- Spine. 2009;15(3418):E298-304.
Corea F. A case of vertebrobasilar stroke -J. Stroke Cerebrovascular diseases. 2004;13(6):259-61.
Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest, 2006.
Ozone nucleolysis in lumber intervertebral disc herniation: non randomized prospective analysis, J of evolution of Med and Dent sci. 2015:4(37)6456-63.
Downloads
Published
How to Cite
Issue
Section
